<DOC>
	<DOCNO>NCT00141349</DOCNO>
	<brief_summary>To determine onset action , safety toleration different formulation dose UK-369,003 patient erectile dysfunction . Patients previously treat PDE5 inhibitor responder drug . Duration treatment 4 week .</brief_summary>
	<brief_title>Assessment Onset , Safety &amp; Toleration UK-369,003 Male Erectile Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<criteria>Erectile dysfunction define DSMIV . Patients PDE5 inhibitor respondent Alpha blocker Nitrates preparation</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2006</verification_date>
</DOC>